Cubist Systematic Strategies, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.01 - $1.82 $37,272 - $67,163	-36,903 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $87,100 - $138,483	-62,662 Reduced 62.94%	36,903 $68,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $126,447 - $340,512	99,565 New	99,565 $196,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $11,776 - $23,677	-12,528 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $47,961 - $299,916	-31,974 Reduced 71.85%	12,528 $23,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $213,164 - $373,371	44,502 New	44,502 $373,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.27B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.